Browsing Tag
Oncology Generics
2 posts
Zydus Lifesciences enters $1.09bn prostate cancer drug market with USFDA green light
Zydus Lifesciences gains USFDA approval for Apalutamide Tablets, 60 mg, expanding its oncology generics portfolio. Find out what this means for investors.
Natco Pharma completes full US generic Revlimid lineup with new lenalidomide strengths
Natco Pharma and Teva Pharmaceuticals launch 2.5 mg and 20 mg generic lenalidomide in US, completing their Revlimid portfolio for multiple myeloma treatment.